• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉搭桥术后患者心肌中PPAR的表达与运动能力

Myocardial Expression of PPAR and Exercise Capacity in Patients after Coronary Artery Bypass Surgery.

作者信息

Wojtkowska Izabela, Bonda Tomasz A, Wolszakiewicz Jadwiga, Osak Jerzy, Tysarowski Andrzej, Seliga Katarzyna, Siedlecki Janusz A, Winnicka Maria M, Piotrowicz Ryszard, Stępińska Janina

机构信息

Institute of Cardiology, Intensive Cardiac Therapy Clinic, Alpejska St. 42, 04-628 Warsaw, Poland.

Department of General and Experimental Pathology, Medical University of Bialystok, Mickiewicza St. 2c, 15-222 Bialystok, Poland.

出版信息

PPAR Res. 2017;2017:1924907. doi: 10.1155/2017/1924907. Epub 2017 Sep 28.

DOI:10.1155/2017/1924907
PMID:29093735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5637858/
Abstract

Activation of PPARs may be involved in the development of heart failure (HF). We evaluated the relationship between expression of PPAR in the myocardium during coronary artery bypass grafting (CABG) and exercise tolerance initially and during follow-up. 6-minute walking test was performed before CABG, after 1, 12, 24 months. Patients were divided into two groups (HF and non-HF) based on left ventricular ejection fraction and plasma proBNP level. After CABG, 67% of patients developed HF. The mean distance 1 month after CABG in HF was 397 ± 85 m versus 420 ± 93 m in non-HF. PPAR mRNA expression was similar in both HF and non-HF groups. 6MWT distance 1 month after CABG was inversely correlated with PPAR level only in HF group. Higher PPAR expression was related to smaller LVEF change between 1 month and 1 year ( = 0.18, < 0.05), especially in patients with HF. Higher initial levels of IL-6 in HF patients were correlated with longer distance in 6MWT one month after surgery and lower PPAR expression. PPAR expression is not related to LVEF before CABG and higher PPAR expression in the myocardium of patients who are developing HF following CABG may have some protecting effect.

摘要

过氧化物酶体增殖物激活受体(PPARs)的激活可能与心力衰竭(HF)的发生发展有关。我们评估了冠状动脉旁路移植术(CABG)期间心肌中PPAR的表达与初始及随访期间运动耐量之间的关系。在CABG前、术后1个月、12个月、24个月进行6分钟步行试验。根据左心室射血分数和血浆脑钠肽前体水平将患者分为两组(HF组和非HF组)。CABG后,67%的患者发生HF。HF组CABG后1个月的平均步行距离为397±85米,而非HF组为420±93米。HF组和非HF组的PPAR mRNA表达相似。仅在HF组中,CABG后1个月的6分钟步行试验距离与PPAR水平呈负相关。较高的PPAR表达与1个月至1年期间较小的左心室射血分数变化相关(r = 0.18,P < 0.05),尤其是在HF患者中。HF患者较高的初始白细胞介素-6水平与术后1个月6分钟步行试验中较长的距离和较低的PPAR表达相关。PPAR表达与CABG前的左心室射血分数无关,CABG后发生HF的患者心肌中较高的PPAR表达可能具有一定的保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/5ebf02766845/PPAR2017-1924907.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/7c351b9ffbfe/PPAR2017-1924907.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/a6cdc92a657a/PPAR2017-1924907.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/0145dc3417c0/PPAR2017-1924907.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/30e265440969/PPAR2017-1924907.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/5ebf02766845/PPAR2017-1924907.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/7c351b9ffbfe/PPAR2017-1924907.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/a6cdc92a657a/PPAR2017-1924907.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/0145dc3417c0/PPAR2017-1924907.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/30e265440969/PPAR2017-1924907.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7417/5637858/5ebf02766845/PPAR2017-1924907.005.jpg

相似文献

1
Myocardial Expression of PPAR and Exercise Capacity in Patients after Coronary Artery Bypass Surgery.冠状动脉搭桥术后患者心肌中PPAR的表达与运动能力
PPAR Res. 2017;2017:1924907. doi: 10.1155/2017/1924907. Epub 2017 Sep 28.
2
PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting.冠心病患者冠状动脉旁路移植术后心力衰竭发展过程中过氧化物酶体增殖物激活受体γ表达水平。
PPAR Res. 2014;2014:242790. doi: 10.1155/2014/242790. Epub 2014 Oct 13.
3
PPARG2 Pro12Ala and TNF -308G>A Polymorphisms Are Not Associated with Heart Failure Development in Patients with Ischemic Heart Disease after Coronary Artery Bypass Grafting.PPARG2基因Pro12Ala多态性和TNF基因-308G>A多态性与冠状动脉旁路移植术后缺血性心脏病患者心力衰竭的发生无关。
PPAR Res. 2019 Jun 2;2019:1932036. doi: 10.1155/2019/1932036. eCollection 2019.
4
Myocardial Function after Coronary Artery Bypass Grafting in Patients with Preoperative Preserved Left Ventricular Ejection Fraction-The Role of the Left Ventricular Longitudinal Strain.冠状动脉旁路移植术后左心室射血分数保留患者的心肌功能——左心室纵向应变的作用。
Medicina (Kaunas). 2023 May 12;59(5):932. doi: 10.3390/medicina59050932.
5
Prognostication in 3-vessel coronary artery disease based on left ventricular ejection fraction during exercise : influence of coronary artery bypass grafting.基于运动时左心室射血分数的三支血管冠状动脉疾病的预后评估:冠状动脉旁路移植术的影响
Circulation. 1999 Aug 31;100(9):924-32. doi: 10.1161/01.cir.100.9.924.
6
Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy.冠状动脉旁路移植术后六分钟步行距离与缺血性心肌病药物治疗的比较
Open Heart. 2018 Feb 20;5(1):e000752. doi: 10.1136/openhrt-2017-000752. eCollection 2018.
7
Long-Term Outcome of Intra-Myocardial Injection of Autologous Bone Marrow Mononuclear Cells Combined with Isolated Coronary Artery Bypass Grafting for Patients with Chronic Ischemic Heart Failure.心肌内注射自体骨髓单个核细胞联合孤立冠状动脉旁路移植术治疗慢性缺血性心力衰竭患者的长期预后
Heart Surg Forum. 2016 Jun 24;19(3):E131-8. doi: 10.1532/hsf.1505.
8
Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial.直接心脏冲击波疗法在接受冠状动脉旁路移植术的缺血性心肌病患者中的安全性和有效性(CAST-HF试验):一项随机对照试验的研究方案
Trials. 2020 May 30;21(1):447. doi: 10.1186/s13063-020-04369-0.
9
Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial-an update.直接心脏冲击波治疗缺血性心肌病患者冠状动脉旁路移植术后的安全性和疗效(CAST-HF 试验):一项随机对照试验的研究方案更新
Trials. 2022 Dec 9;23(1):988. doi: 10.1186/s13063-022-06931-4.
10
Impact of left ventricular ejection fraction on clinical outcomes after left main coronary artery revascularization: results from the randomized EXCEL trial.左心室射血分数对左主干冠状动脉血运重建术后临床结局的影响:随机EXCEL试验结果
Eur J Heart Fail. 2020 May;22(5):871-879. doi: 10.1002/ejhf.1681. Epub 2020 Feb 11.

引用本文的文献

1
PPARG2 Pro12Ala and TNF -308G>A Polymorphisms Are Not Associated with Heart Failure Development in Patients with Ischemic Heart Disease after Coronary Artery Bypass Grafting.PPARG2基因Pro12Ala多态性和TNF基因-308G>A多态性与冠状动脉旁路移植术后缺血性心脏病患者心力衰竭的发生无关。
PPAR Res. 2019 Jun 2;2019:1932036. doi: 10.1155/2019/1932036. eCollection 2019.

本文引用的文献

1
Inflammatory biomarkers and effect of exercise on functional capacity in patients with heart failure: Insights from a randomized clinical trial.炎症生物标志物及运动对心力衰竭患者功能能力的影响:一项随机临床试验的见解
Eur J Prev Cardiol. 2017 May;24(8):808-817. doi: 10.1177/2047487317690458. Epub 2017 Jan 30.
2
Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis.吡格列酮在胰岛素抵抗、糖尿病前期和 2 型糖尿病患者中的心血管结局:系统评价和荟萃分析。
BMJ Open. 2017 Jan 5;7(1):e013927. doi: 10.1136/bmjopen-2016-013927.
3
Pioglitazone improves whole-body aerobic capacity and skeletal muscle energy metabolism in patients with metabolic syndrome.
吡格列酮可改善代谢综合征患者的全身有氧能力和骨骼肌能量代谢。
J Diabetes Investig. 2017 Jul;8(4):535-541. doi: 10.1111/jdi.12606. Epub 2017 Jan 31.
4
Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat.雷米普利可恢复过氧化物酶体增殖物激活受体β/δ(PPARβ/δ)和过氧化物酶体增殖物激活受体γ(PPARγ)的表达,并降低心脏烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶,但在大鼠严重蒽环类药物诱导的心肌病中,未能恢复心脏功能及伴随的肌球蛋白重链比例变化。
Eur J Pharmacol. 2016 Nov 15;791:244-253. doi: 10.1016/j.ejphar.2016.08.040. Epub 2016 Aug 31.
5
Molecular profiling of dilated cardiomyopathy that progresses to heart failure.进展为心力衰竭的扩张型心肌病的分子特征分析。
JCI Insight. 2016 May 5;1(6). doi: 10.1172/jci.insight.86898.
6
Activation of Peroxisome Proliferator-activated Receptor γ Prevents Development of Heart Failure With Preserved Ejection Fraction; Inhibition of Wnt-β-catenin Signaling as a Possible Mechanism.过氧化物酶体增殖物激活受体γ的激活可预防射血分数保留的心力衰竭的发生;抑制Wnt-β-连环蛋白信号通路可能是其机制之一。
J Cardiovasc Pharmacol. 2016 Aug;68(2):155-61. doi: 10.1097/FJC.0000000000000397.
7
Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.过氧化物酶体增殖物激活受体与心脏:过去的经验教训及未来方向
PPAR Res. 2015;2015:271983. doi: 10.1155/2015/271983. Epub 2015 Oct 26.
8
PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting.冠心病患者冠状动脉旁路移植术后心力衰竭发展过程中过氧化物酶体增殖物激活受体γ表达水平。
PPAR Res. 2014;2014:242790. doi: 10.1155/2014/242790. Epub 2014 Oct 13.
9
Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction.射血分数保留的心力衰竭患者运动不耐受的机制:外周氧摄取异常的作用
Circ Heart Fail. 2015 Mar;8(2):286-94. doi: 10.1161/CIRCHEARTFAILURE.114.001825. Epub 2014 Oct 24.
10
Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?白细胞介素-6 肌因子信号在骨骼肌中的作用:一把双刃剑?
FEBS J. 2013 Sep;280(17):4131-48. doi: 10.1111/febs.12338. Epub 2013 Jun 18.